Real-life evaluation of the effectiveness of biologics for chronic rhinosinusitis with nasal polyps in Europe: a Delphi study to define key variables for the INVENT registry

BackgroundChronic rhinosinusitis with nasal polyps (CRSwNP) is a persistent inflammatory condition often associated with type 2 inflammation. While biologics are a promising treatment for patients with uncontrolled CRSwNP, real-world evidence is needed to optimize their use. The InternatioNal seVerE...

Full description

Bibliographic Details
Published in:	Frontiers in Allergy
Main Authors:	Vibeke Backer, Eugenio De Corso, Geoffrey Mortuaire, Emmanuel Prokopakis, Anette Drøhse Kjeldsen, Philippe Gevaert, Adam M. Chaker, Luisa Azevedo, Christian von Buchwald, Emilie Bequignon, Eliza Brozek-Madry, Jannis Constantinidis, Marjolein Cornet, Wytske J. Fokkens, Peter G. Gibson, Aleksander Grande Hansen, Joaquim Mullol, Sietze Reitsma, Sanna Toppila-Salmi, Michael B. Soyka, Martin Wagenmann, Peter W. Hellings
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-10-01
Subjects:	chronic rhinosinusitis with nasal polyp CRSwNP type-2 inflammation comorbididites monoclonal antibodies systematic assessment
Online Access:	https://www.frontiersin.org/articles/10.3389/falgy.2025.1680703/full

Similar Items

Airway Epithelial Dynamics in Allergy and Related Chronic Inflammatory Airway Diseases
by: Anu Laulajainen-Hongisto, et al.
Published: (2020-03-01)

ULANC - EUFOREA workshop 2024: bringing the concept of global airways to the frontline of medical care
by: D. M. Conti, et al.
Published: (2025-06-01)

Editorial: Ketogenic Diet in Epilepsy and Associated Comorbidities: Clinical Efficacy and Mechanisms
by: Tianfu Li, et al.
Published: (2020-02-01)

Using machine learning for the personalised prediction of revision endoscopic sinus surgery.
by: Mikko Nuutinen, et al.
Published: (2022-01-01)

Study protocol for a randomized double-blinded placebo-controlled trial on ASA therapy for patients with chronic rhinosinusitis with nasal polyps, NSAID-exacerbated respiratory disease, and asthma
by: Sanna Toppila-Salmi, et al.
Published: (2025-05-01)

Indoleamine 2,3-dioxygenase expression in patients with allergic rhinitis: a case-control study
by: Luukkainen Annika, et al.
Published: (2011-12-01)

Deaths from tuberculosis: differences between tuberculosis-related and non-tuberculosis-related deaths
by: Yun-Jeong Jeong, et al.
Published: (2023-09-01)

Diseases with oral manifestations among adult asthmatics in Finland: a population-based matched cohort study
by: Juha Pekkanen, et al.
Published: (2021-12-01)

Predictors of revision endoscopic sinus surgery in Finnish patients with chronic rhinosinusitis with nasal polyps
by: Sanna Toppila‐Salmi, et al.
Published: (2025-02-01)

Allergic multimorbidity is associated with self‐reported anaphylaxis in adults—A cross‐sectional questionnaire study
by: Tuuli Thomander, et al.
Published: (2022-07-01)

The burden of chronic rhinosinusitis with nasal polyps and its relation to asthma in Finland
by: Sanna Toppila‐Salmi, et al.
Published: (2022-10-01)

Comorbidities associated with adult asthma: a population-based matched cohort study in Finland
by: Juha Pekkanen, et al.
Published: (2024-03-01)

Study protocol for a randomized double-blinded placebo-controlled trial on mepolizumab for patients with chronic rhinosinusitis with nasal polyps, NSAID exacerbated respiratory disease and asthma
by: Annina Lyly, et al.
Published: (2025-03-01)

Being born in autumn or winter is associated with asthma and allergic rhinitis in Finland
by: Riikka Hänninen, et al.
Published: (2024-07-01)

A retrospective cohort study on European Reference Network for Rare Vascular Diseases 5 outcome measures for Hereditary Haemorrhagic Telangiectasia in Denmark
by: Troels Hvelplund, et al.
Published: (2022-01-01)

Real‐world drug use in asthma, chronic obstructive pulmonary disease, rhinitis, cough, and cold in Finland from 1990 to 2021: Association with reduced disease burden
by: Tiina Mattila, et al.
Published: (2024-04-01)

Lung function and side effects of Aspirin desensitization: a real world study
by: Heikki Turpeinen, et al.
Published: (2021-01-01)

Temporal changes in blood biomarkers associated with sleep apnoea severity: a retrospective cohort study in Finland
by: Satu Strausz, et al.
Published: (2025-02-01)

White Paper on European Patient Needs and Suggestions on Chronic Type 2 Inflammation of Airways and Skin by EUFOREA
by: Louise De Prins, et al.
Published: (2022-06-01)

Adult-onset asthma, allergy, and aspirin hypersensitivity associate with self-reported food avoidance
by: Marie Lundberg, et al.
Published: (2024-12-01)

The relative proportion of comorbidities among rhinitis and rhinosinusitis patients and their impact on visit burden
by: Mikko Nuutinen, et al.
Published: (2022-07-01)

Tobacco Products, Periodontal Health and Education Level: Cohort Study from Sweden
by: Anna Julkunen-Iivari, et al.
Published: (2020-08-01)

Radiological score, asthma and NSAID‐exacerbated respiratory disease predict relapsing chronic rhinosinusitis
by: Markus Lilja, et al.
Published: (2025-04-01)

Multidisciplinary approaches to identifying and managing global airways disease: Expert recommendations based on qualitative discussions
by: Vibeke Backer, et al.
Published: (2023-02-01)

Comorbidities of chronic rhinosinusitis in children and adults
by: Aada Murtomäki, et al.
Published: (2024-04-01)

Factors affecting upper airway control of NSAID‐exacerbated respiratory disease: A real‐world study of 167 patients
by: Annina Lyly, et al.
Published: (2021-03-01)

Risk factors of NSAID‐exacerbated respiratory disease: A population‐based study
by: Alma Helevä, et al.
Published: (2023-08-01)

Pre-asthma: a useful concept? A EUFOREA paper. Part 2—late onset eosinophilic asthma
by: G. K. Scadding, et al.
Published: (2024-05-01)

The bleeding diathesis in patients with hereditary haemorrhagic telangiectasia is not due to impaired platelet function
by: Anne Lørup Lyster, et al.
Published: (2023-11-01)

Multi-Disciplinary Expert Perspective on the Management of Type 2 Inflammation-Driven Severe CRSwNP: A Brief Overview of Pathophysiology and Recent Clinical Insights
by: Toppila-Salmi S, et al.
Published: (2024-05-01)

Characterization of Chronic Rhinosinusitis Patients Based on Markers of Type 2 Inflammation: Findings From the European CRS Outcome Registry (CHRINOSOR)
by: Carlo Cavaliere, et al.
Published: (2025-09-01)

The attenuation of hearing protectors against high-level shooting impulses
by: E. Toppila, et al.
Published: (2004-01-01)

Radiological score of computed tomography scans predicts revision surgery for chronic rhinosinusitis
by: Markus Lilja, et al.
Published: (2022-02-01)

Genome-wide association study indicates novel associations of annexin A13 to secretory and GAS2L2 with mucous otitis media
by: Argyro Bizaki-Vallaskangas, et al.
Published: (2024-08-01)

Liprin‐α1 contributes to oncogenic MAPK signaling by counteracting ERK activity
by: Henna Pehkonen, et al.
Published: (2024-03-01)

Multiple reasons underlaying uncontrolled disease in the majority of chronic rhinosinusitis patients
by: An-Sofie Viskens, et al.
Published: (2022-12-01)

Hearing loss among classical-orchestra musicians
by: Esko Toppila, et al.
Published: (2011-01-01)

Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
by: Dorien Van Broeck, et al.
Published: (2023-04-01)

The Association of CD8+ Cytotoxic T Cells and Granzyme B+ Lymphocytes with Immunosuppressive Factors, Tumor Stage and Prognosis in Cutaneous Melanoma
by: Satu Salmi, et al.
Published: (2022-12-01)

Satisfaction with Maxillary Sinus Surgery Might be Influenced by Risk Factors
by: Jyri P. Myller M.D., et al.
Published: (2013-03-01)